Prevalence and Clinical Severity of Cutaneous Lupus Erythematosus

Description

The Cutaneous Lupus Erythematosus (CLE) database, established in 2006, is a multi-site database between the University of Pennsylvania and the University of Texas Southwestern (UTSW).

Conditions

Cutaneous Lupus Erythematosus (CLE)

Talk to us

Study Overview

On this page

Study Details

Study overview

The Cutaneous Lupus Erythematosus (CLE) database, established in 2006, is a multi-site database between the University of Pennsylvania and the University of Texas Southwestern (UTSW).

Prevalence and Clinical Severity of Cutaneous Lupus Erythematosus

Prevalence and Clinical Severity of Cutaneous Lupus Erythematosus

Condition
Cutaneous Lupus Erythematosus (CLE)
Intervention / Treatment

-

Contacts and Locations

Philadelphia

Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States, 19104

Dallas

University of Texas Southwestern, Dallas, Texas, United States, 75390

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Subjects who meet the criteria for having CLE, using the Gilliam classifications, and/or a diagnosis of systemic lupus erythematosus (SLE), using the American Rheumatism Association/American College of Rheumatology criteria. Subjects must be 18 years or older.
  • * All subjects who do not meet the criteria for having CLE. Subjects who meet the criteria for CLE but who are not yet 18 years old

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Pennsylvania,

Victoria Werth, M.D., PRINCIPAL_INVESTIGATOR, University of Pennsylvania

Study Record Dates

2025-01-02